ChinaTalk Biotech 101
21 snips
Mar 25, 2024 
Jason Kelly, the Co-founder and CEO of Ginkgo Bioworks, and Michelle Rozo, VP of Technical Capabilities at In-Q-Tel, dive deep into the world of biotechnology. They discuss how the U.S. government transformed biotech into a $1 trillion industry and explore the transformative potential of AI in drug discovery. The duo also examines China’s growing ambitions in this field, raising questions about U.S. competitiveness. Additionally, they highlight ethical challenges and the need for strategic policies to foster innovation and enhance national security.
AI Snips
Chapters
Transcript
Episode notes
Biotechnology as Programming
- DNA is code, like software, but for biology.
- Programming DNA allows cells to perform new functions, like producing human insulin in bacteria.
Genentech's Insulin
- Genentech, the first biotech company, used recombinant DNA to produce human insulin in bacteria.
- This replaced pig-derived insulin, benefiting diabetics.
Government's Role in Biotech
- Government-funded research on restriction enzymes and the operon were crucial for Genentech's success.
- Basic biological research is essential for biotech's advancement.